FROM THE EDITOR-IN-CHIEF
T cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD
Forward Look
Targeted Chemotherapy | Drug Combo Targets Polyp Growth | FDA Acts to Curb Nicotine Use | Cloning Cancer | Putting Age in the Cancer Picture | Back to School | What’s Next?
POLICY MATTERS
The number of cancer survivors is growing. We must step up efforts to meet their needs.
by Elizabeth M. Jaffee, MD
YOUR CANCER GUIDE
A second opinion can provide additional information to determine the best treatment course.
by Hester Hill Schnipper
CAREGIVING WITH CONFIDENCE
Recognize the signs of a serious mental illness and get help if you need it.
by Lisa O’Leary
Survivor Profile
Janet Freeman-Daily helps put patients at the center of lung cancer research.
by Robin Meadows
People with metastatic breast cancer are demanding to be seen, counted and included in breast cancer research.
by Sue Rochman
Cancer rehabilitation can help patients before and after treatment, but it’s still not widely used.
by Cameron Walker
After decades without treatment advances, options for patients with bladder cancer are now more numerous.
by Kendall K. Morgan
Healthy Habits
Go Fish | Against the Clock
Q&A
Palliative care specialist Jessica Nutik Zitter offers tips to help ensure that patients’ values guide end-of-life decisions.
by Marci A. Landsmann
Sound Advice
A patient support expert offers guidance on how to respond to news of a friend’s cancer diagnosis.
Get Involved
Help with Hope delivers care packages to young people whose mother or father has received a cancer diagnosis.
by Lindsey Konkel
Tanya Waring-Hearn, Amy Rowley, Elsie Young.
Socioeconomic factors and racism can lead to poorer health outcomes for Black Americans. Genetics may also be a factor behind increased mortality rates.
A study shows that a blood test for gastrointestinal tumor mutations gave results in a third of the time needed for solid tissue testing. Patients who received the blood test were more likely to enroll in clinical trials.
by Emma Yasinski
The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it’s not clear the biomarker is valid across all cancer types.
by Anna Azvolinsky
Going through cancer treatment and ensuing complications is never easy, but surrounding yourself with the right key players can help, writes pancreatic cancer survivor Rob Weker.
by Rob Weker
This genome editing system allows researchers to accurately delete, add or modify specific regions of the genome.
The leading cause of liver cancer is infection with the hepatitis B virus or the hepatitis C virus.
The passing of Alex Trebek has brought pancreatic cancer into the public consciousness.
Handle With Care
donate to the AACR